Elwatidy A M, Fadalah M A, Bukhari E A, Aljubair K A, Syed A, Ashmeg A K, Alfagih M R
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
Ann Thorac Surg. 1999 Aug;68(2):447-53. doi: 10.1016/s0003-4975(99)00359-8.
This study evaluated the myocardial protective strategies in isolated coronary bypass surgeries.
One hundred and twenty-eight patients were prospectively randomized to 3 techniques of myocardial protection; group I (n = 47) antegrade/retrograde tepid blood cardioplegia, group II (n = 40) antegrade/retrograde cold blood cardioplegia with topical cooling, group III (n = 41) antegrade crystalloid cardioplegia with topical cooling.
The incidence of spontaneous defibrillation was significantly higher in group I (p < 0.001) while the incidence of low cardiac output was not different between the 3 groups. The incidence of ventricular arrhythmia was higher in group III (p < 0.016 group III vs I). There was no significant statistical difference in hemodynamic recovery between the 3 groups. CK-MB levels were significantly lower in group I versus the other 2 groups, (p = 0.0013, 0.04). Acid release and oxygen extraction were higher in group II than in group I (p = 0.06) during cardioplegia and reperfusion. Lactate release was less in group I at the release of aortic cross-clamp, and reperfusion. There was no significant difference between the 3 groups in ICU stay, ventilation time, or hospital complications.
Tepid blood cardioplegia showed superiority in metabolic and functional recovery, whereas crystalloid cardioplegia had the highest incidence of postoperative arrhythmias. There was no significant statistical difference between the 3 groups in hospital mortality and morbidity.
本研究评估了体外循环冠状动脉搭桥手术中的心肌保护策略。
128例患者被前瞻性随机分为3种心肌保护技术组;I组(n = 47)顺行/逆行温血心脏停搏液灌注,II组(n = 40)顺行/逆行冷血心脏停搏液灌注并局部降温,III组(n = 41)顺行晶体心脏停搏液灌注并局部降温。
I组自发电除颤发生率显著更高(p < 0.001),而3组间低心排血量发生率无差异。III组室性心律失常发生率更高(III组与I组比较,p < 0.016)。3组间血流动力学恢复无显著统计学差异。与其他2组相比,I组肌酸激酶同工酶(CK-MB)水平显著更低(p = 0.0013,0.04)。心脏停搏期及再灌注期II组的酸释放和氧摄取高于I组(p = 0.06)。主动脉阻断松开及再灌注时I组的乳酸释放更少。3组在重症监护病房停留时间、通气时间或医院并发症方面无显著差异。
温血心脏停搏液在代谢和功能恢复方面显示出优势,而晶体心脏停搏液术后心律失常发生率最高。3组在医院死亡率和发病率方面无显著统计学差异。